CoChat
Sign Up
Cited by 33

In‐Line Product Quality Monitoring During Biopharmaceutical Manufacturing Using Computational Raman Spectroscopy

Wang, Jiarui, Chen, Jingyi, Studts, Joey, Wang, Gang·2023·mAbs
DOI 10.1080/19420862.2023.2220149PMC PMC10251777
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19420862.2023.2220149

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Raman spectroscopy implemented in-line measured product aggregation and fragmentation in real time, with a calibration model achieving accurate quality measurements every 38 s.

    “Wang et al. implemented Raman spectroscopy in‐line for measuring product aggregation and fragmentation in real time, developed a calibration model, achieving accurate quality measurements every 38 s.”

    From Current PAT Landscape in the Downstream Processing of Biopharmaceuticals (2025) · cites this paper as [70]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 38

  1. [2]Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012; 11(3): 191– 11. doi: 10.1038/nrd3681. 22378269 · DOI · Paper page
  2. [3]Ringel MS, Scannell JW, Baedeker M, Schulze U. Breaking Eroom’s Law. Nat Rev Drug Discov. 2020; 19: 833– 34. doi: 10.1038/d41573-020-00059-3. 32300238 · DOI
  3. [4]Ochoa D, Karim M, Ghoussaini M, Hulcoop DG, McDonagh EM, Dunham I. Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs. Nat Rev Drug Discov. 2022; 21(8): 551– 551. doi: 10.1038/d41573-022-00120-3. 35804044 · DOI
  4. [5]Kelley B. Developing therapeutic monoclonal antibodies at pandemic pace. Nat Biotechnol. 2020; 38: 540– 45. doi: 10.1038/s41587-020-0512-5. 32317764 PMC7173776 · DOI
  5. [6]Farid SS, Baron M, Stamatis C, Nie W, Coffman J. Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D. MAbs. 2020; 12(1): 1754999. doi: 10.1080/19420862.2020.1754999. 32449439 PMC7531566 · DOI
  6. [7]Gillespie C, Wasalathanthri DP, Ritz DB, Zhou G, Davis KA, Wucherpfennig T, Hazelwood N. Systematic assessment of process analytical technologies for biologics. Biotechnol Bioeng. 2022; 119(2): 423– 34. doi: 10.1002/bit.27990. 34778948 · DOI
  7. [8]Crowell LE, Rodriguez SA, Love KR, Cramer SM, Love JC. Rapid optimization of processes for the integrated purification of biopharmaceuticals. Biotechnol Bioeng. 2021; 118: 3435– 46. doi: 10.1002/bit.27767. 33782945 PMC8453909 · DOI
  8. [10]Carter PJ, Lazar GA. Next generation antibody drugs: pursuit of the “high-hanging fruit. Nat Rev Drug Discov. 2018; 17(3): 197– 223. doi: 10.1038/nrd.2017.227. 29192287 · DOI
  9. [11]Erickson J, Baker J, Barrett S, Brady C, Brower M, Carbonell R, Charlebois T, Coffman J, Connell‐Crowley L, Coolbaugh M, et al. End‐to‐end collaboration to transform biopharmaceutical development and manufacturing. Biotechnol Bioeng. 2021; 118(9): 3302– 12. doi: 10.1002/bit.27688. 33480041 PMC8451863 · DOI
  10. [12]Eon‐Duval A, Broly H, Gleixner R. Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach. Biotechnol Progr. 2012; 28(3): 608– 22. doi: 10.1002/btpr.1548. 22473974 · DOI · Paper page
  11. [13]Pedro MNS, Klijn ME, Eppink MH, Ottens M. September. Process analytical technique (PAT) miniaturization for monoclonal antibody aggregate detection in continuous downstream processing. J Chem Technology Biotechnology. 97(9): 2022.
  12. [15]Feidl F, Garbellini S, Luna MF, Vogg S, Souquet J, Broly H, Morbidelli M, Butté A. Combining mechanistic modeling and raman spectroscopy for monitoring antibody chromatographic purification. Process. 2019; 7(10): 683. doi: 10.3390/pr7100683. · DOI · Paper page
  13. [16]Rolinger L, Rüdt M, Hubbuch J. Comparison of UV‐ and Raman‐based monitoring of the protein a load phase and evaluation of data fusion by PLS models and CNNs. Biotechnol Bioeng. 2021; 118(11): 4255– 68. doi: 10.1002/bit.27894. 34297358 · DOI · Paper page
  14. [17]Zhang C, Springall JS, Wang X, Barman I. Rapid, quantitative determination of aggregation and particle formation for antibody drug conjugate therapeutics with label-free Raman spectroscopy. Anal Chim Acta. 2019; 1081: 138– 45. doi: 10.1016/j.aca.2019.07.007. 31446951 PMC6750807 · DOI
  15. [19]Wei B, Woon N, Dai L, Fish R, Tai M, Handagama W, Yin A, Sun J, Maier A, McDaniel D, et al. Multi-attribute Raman spectroscopy (MARS) for monitoring product quality attributes in formulated monoclonal antibody therapeutics. MAbs. 2021; 14(1): 2007564. doi: 10.1080/19420862.2021.2007564. PMC8726703 34965193 · DOI
  16. [20]Akhgar CK, Ebner J, Spadiut O, Schwaighofer A, Lendl B. QCL–IR spectroscopy for in-line monitoring of proteins from preparative ion-exchange chromatography. Anal Chem. 2022; 94(14): 5583– 90. doi: 10.1021/acs.analchem.1c05191. 35353485 PMC9008697 · DOI
  17. [21]Brestrich N, Rüdt M, Büchler D, Hubbuch J. Selective protein quantification for preparative chromatography using variable pathlength UV/Vis spectroscopy and partial least squares regression. Chem Eng Sci. 2018; 176: 157– 64. doi: 10.1016/j.ces.2017.10.030. · DOI
  18. [22]Taraban MB, Briggs KT, Merkel P, Yu YB. Flow water proton NMR: in-line process analytical technology for continuous biomanufacturing. Anal Chem. 2019; 91(21): 13538– 46. doi: 10.1021/acs.analchem.9b02622. 31550145 · DOI
  19. [23]Zhou C, Qi W, Lewis EN, Carpenter JF. Concomitant Raman spectroscopy and dynamic light scattering for characterization of therapeutic proteins at high concentrations. Anal Biochem. 2015; 472: 7– 20. doi: 10.1016/j.ab.2014.11.016. 25475399 · DOI
  20. [24]Smith E, Dent G. 25 February. 2019. Modern Raman Spectroscopy: A Practical Approach. John Wiley & Sons Ltd. 9781119440550.
  21. [25]McAvan BS, Bowsher LA, Powell T, O’Hara JF, Spitali M, Goodacre R, Doig AJ. Raman spectroscopy to monitor post-translational modifications and degradation in monoclonal antibody therapeutics. Anal Chem. 2020; 92(15): 10381– 89. doi: 10.1021/acs.analchem.0c00627. 32614170 PMC7467412 · DOI · Paper page
  22. [26]Tulsyan A, Wang T, Schorner G, Khodabandehlou H, Coufal M, Undey C. Automatic real‐time calibration, assessment, and maintenance of generic Raman models for online monitoring of cell culture processes. Biotechnol Bioeng. 2020; 117(2): 406– 16. doi: 10.1002/bit.27205. 31631322 · DOI · Paper page
  23. [27]Yilmaz D, Mehdizadeh H, Navarro D, Shehzad A, O’Connor M, McCormick P. Application of Raman spectroscopy in monoclonal antibody producing continuous systems for downstream process intensification. Biotechnol Progr. 2020; 36(3): e2947. doi: 10.1002/btpr.2947. 31837253 · DOI · Paper page
  24. [30]Patel BA, Gospodarek A, Larkin M, Kenrick SA, Haverick MA, Tugcu N, Brower MA, Richardson DD. Multi-angle light scattering as a process analytical technology measuring real-time molecular weight for downstream process control. MAbs. 2018; 10: 945– 50. doi: 10.1080/19420862.2018.1505178. 30130442 PMC6204791 · DOI · Paper page
  25. [31]Rolinger L, Rüdt M, Diehm J, Chow-Hubbertz J, Heitmann M, Schleper S, Hubbuch J. Multi-attribute PAT for UF/DF of proteins—monitoring concentration, particle sizes, and buffer exchange. Anal Bioanal Chem. 2020; 412: 2123– 36. doi: 10.1007/s00216-019-02318-8. 32072210 · DOI · Paper page
  26. [32]Rolinger L, Rüdt M, Hubbuch J. A critical review of recent trends, and a future perspective of optical spectroscopy as PAT in biopharmaceutical downstream processing. Anal Bioanal Chem. 2020; 412: 2047– 64. doi: 10.1007/s00216-020-02407-z. 32146498 PMC7072065 · DOI · Paper page
  27. [33]Saleh D, Wang G, Müller B, Rischawy F, Kluters S, Studts J, Hubbuch J. Straightforward method for calibration of mechanistic cation exchange chromatography models for industrial applications. Biotechnol Progr. 2020; 36(4): e2984. doi: 10.1002/btpr.2984. 32087049 · DOI
  28. [34]Rischawy F, Saleh D, Hahn T, Oelmeier S, Spitz J, Kluters S. Good modeling practice for industrial chromatography: mechanistic modeling of ion exchange chromatography of a bispecific antibody. Comput Chem Eng. 2019; 130: 106532. doi: 10.1016/j.compchemeng.2019.106532. · DOI
  29. [36]Guo S, Popp J, Bocklitz T. Chemometric analysis in Raman spectroscopy from experimental design to machine learning–based modeling. Nat Protoc. 2021; 16: 5426– 59. doi: 10.1038/s41596-021-00620-3. 34741152 · DOI · Paper page
  30. [37]Ramakrishna A, Prathap V, Maranholkar V, Rathore AS. Multi-wavelength UV-based PAT tool for measuring protein concentration. J Pharmaceut Biomed. 2022; 207: 114394. doi: 10.1016/j.jpba.2021.114394. 34607167 · DOI
  31. [38]Graf A, Lemke J, Schulze M, Soeldner R, Rebner K, Hoehse M, Matuszczyk J. A novel approach for non-invasive continuous in-line control of perfusion cell cultivations by raman spectroscopy. Front Bioeng Biotech. 2022; 10: 719614. doi: 10.3389/fbioe.2022.719614. PMC9081366 35547168 · DOI
  32. [39]Zhang Z-M, Chen S, Liang Y-Z. Baseline correction using adaptive iteratively reweighted penalized least squares. Analyst (Lond). 2010; 135: 1138– 46. doi: 10.1039/b922045c. 20419267 · DOI
  33. [40]Rolinger L, Hubbuch J, Rüdt M. Monitoring of ultra- and diafiltration processes by Kalman-filtered Raman measurements. Anal Bioanal Chem. 2023; 415: 841– 54. doi: 10.1007/s00216-022-04477-7. 36651972 PMC9883314 · DOI
  34. [41]Zhu G, Zhu X, Fan Q, Wan X. Raman spectra of amino acids and their aqueous solutions. Spectrochimica Acta Part Mol Biomol Spectrosc. 2011; 78(3): 1187– 95. doi: 10.1016/j.saa.2010.12.079. 21242101 · DOI
  35. [42]Tulsyan A, Garvin C, Undey C. Industrial batch process monitoring with limited data. J Process Contr. 2019; 77: 114– 33. doi: 10.1016/j.jprocont.2019.03.002. · DOI
  36. [43]Nowak C, Cheung JK, Dellatore SM, Katiyar A, Bhat R, Sun J, Ponniah G, Neill A, Mason B, Beck A, et al. Forced degradation of recombinant monoclonal antibodies: a practical guide. MAbs. 2017; 9(8): 1217– 30. doi: 10.1080/19420862.2017.1368602. 28853987 PMC5680805 · DOI
  37. [44]AL de F e S, Elcoroaristizabal S, Ryder AG. Multi-attribute quality screening of immunoglobulin G using polarized excitation emission matrix spectroscopy. Anal Chim Acta. 2020; 1101: 99– 110. doi: 10.1016/j.aca.2019.12.020. 32029125 · DOI
  38. [45]Akhgar CK, Ebner J, Alcaraz MR, Kopp J, Goicoechea H, Spadiut O, Schwaighofer A, Lendl B. Application of quantum cascade laser-infrared spectroscopy and chemometrics for in-line discrimination of coeluting proteins from preparative size exclusion chromatography. Anal Chem. 2022; 94(32): 11192– 200. doi: 10.1021/acs.analchem.2c01542. 35926134 PMC9386682 · DOI

Cited by

Sorted by citations

Authors
Wang, J., Chen, J., Studts, J., & Wang, G.
Affiliations
Boehringer Ingelheim Pharma GmbH/Co. KG
ORCID
Wang, Gang
Venue
mAbs
Publisher
Informa UK Limited
Published
2023-06-08
Volume
15
Issue
1
ISSN
  • 1942-0862
  • 1942-0870
DOI
10.1080/19420862.2023.2220149
PMC
PMC10251777
Cited by
33
References
3
Language
en
Licence
creativecommons.org/licenses/by-nc/4.0/ (vor)
Funders
Boehringer Ingelheim Pharma GmbH & Co. KG

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review